Wonderland 2023 is just around the corner and the industry’s leading psychedelic medicine event has expanded its scope to include longevity and mental health.
Taking this next step to lead the way into the future of wellness is a massive undertaking — one that wouldn’t be possible without the participation of industry leaders and innovators at our annual Wonderland event. They are crucial to both the Wonderland conference and the future of the psychedelic medicine industry.
So it’s an honor for Microdose to announce Dr. Sam Clark, Founder and CEO of Terran Biosciences, as Keynote Presenter and major participant at Wonderland 2023.
Dr. Clark is a multi-published neuroscientist and innovator with over 200 patent applications. He earned his MD and PhD degrees from Columbia University and his BS degree in neuroscience from MIT. He founded Terran Biosciences with the goal of creating a platform biotech company to transform the approach to therapeutics and technologies in neuropsychiatry.
In his talk entitled “Longevity and the Aging Brain: A Novel Psychedelic-based Therapeutic for Neuroregeneration and Rejuvenation,” Dr. Clark will present groundbreaking results from analysis of a clinical imaging study supporting the mechanism of a psychedelic-based therapeutic for neuroregeneration being developed for at-home use.
“Our mission is rooted in creating a future that includes treating aging-related diseases through enhanced brain function and rejuvenation,” said Dr. Clark. This will be the first presentation of imaging data in humans supporting that the effects of a psychedelic on global brain connectivity and functional neuronal connectivity occur in the absence of a perceptual trip.
In addition to presenting the Keynote, Dr. Clark will lead a workshop and will be speaking on
two panels:
- Thursday, November 9th, 3:00 pm EST: Keynote – Longevity and the Aging Brain: A Novel Psychedelic-based Therapeutic for Neuroregeneration and Rejuvenation
- Friday, November 10th, 2:00 pm EST: Workshop – Finding the Path at the Intersection of Biopharma, Psychedelics, and Longevity
- Friday, November 10th, 10:00 am EST: Patented Psychedelics: The Growing Pharma Field
- Friday, November 11th, 12:00 pm EST: Designing the Future: Safer and Effective Psychoactive Compounds for Mental Health
About Terran Biosciences
Terran Biosciences is a biotech platform company developing a portfolio of therapeutics and technologies for patients with neurological and psychiatric diseases. Terran has built a CNS-focused, tech-enabled drug development platform, and is rapidly advancing a number of late-stage assets, which include novel psychedelic-based therapeutics. With numerous discoveries and more than 200 patent applications in the space, Terran is a leader in developing therapies that bridge the gap between biopharma, psychedelics, and longevity. Follow Terran on LinkedIn and X.
